Laurus Labs Ltd fell for a fifth straight session today. The stock is quoting at Rs 463.95, down 4.42% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.06% on the day, quoting at 25392.05. The Sensex is at 83172.83, up 0.27%.Laurus Labs Ltd has gained around 6.07% in last one month.Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has increased around 2.13% in last one month and is currently quoting at 23025.2, down 0.76% on the day. The volume in the stock stood at 24.45 lakh shares today, compared to the daily average of 26.51 lakh shares in last one month. The benchmark September futures contract for the stock is quoting at Rs 465.85, down 3.9% on the day. Laurus Labs Ltd jumped 17.43% in last one year as compared to a 27.59% rally in NIFTY and a 47.81% spurt in the Nifty Pharma index.The PE of the stock is 109.21 based on TTM earnings ending June 24.Powered by Capital Market - Live

Laurus Labs announced the inauguration of its state of the art new R&D center at IKP Knowledge Park, Plot No DS15, Kolthur Shamirpet Medchal Telangana. Key highlights: - Total investment incurred for setting up the new R&D Rs 250 crore - 2,00,000 Square foot facility equipped with modern laboratories and infrastructure - R&D Center to support the CDMO business of Laurus Labs - Will provide job opportunities to over 800 peoplePowered by Capital Market - Live

The pharmaceutical company said that its API manufacturing facility located at Hyderabad has completed the United States Food and Drug Administration (USFDA) inspection without any 483 observation. The USFDA conducted the inspection from 9 September 2024 to 13 September 2024. Laurus Labs' API manufacturing facility, located at DS-1, IKP Knowledge Park, Genome Valley, Shameerpet, Telangana is instrumental in developing active pharmaceutical ingredients, bolstering the company's ability to deliver high-quality, innovative pharmaceutical solutions to its global customers. Laurus Labs is a fully integrated pharmaceutical and biotechnology company, with a leadership position in generic active pharmaceutical ingredients (APIs) and a major focus on anti-retroviral, oncology drugs, cardiovascular, gastro and hepatitis C therapeutics. The company also develops and manufactures oral solid formulations, provide contract research and manufacturing services (CRAMS) to global pharma companies. The company's consolidated net profit dropped 49.7% to Rs 12.51 crore in Q1 FY24 as against Rs 24.85 crore reported in Q1 FY24. Net sales was at Rs 1,194.91 crore in Q1 FY25, up 1.1% from Rs 1,181.79 crore recorded in the same period a year ago. Shares of Laurus Labs shed 0.25% to settle at Rs 505.70 on Friday, 13 September 2024.Powered by Capital Market - Live

Laurus Labs Ltd is up for a third straight session in a row. The stock is quoting at Rs 496.5, up 4.39% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.06% on the day, quoting at 25182.65. The Sensex is at 82274.5, down 0.09%. Laurus Labs Ltd has risen around 17.43% in last one month. Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has risen around 8.25% in last one month and is currently quoting at 23184.4, up 0.68% on the day. The volume in the stock stood at 77.3 lakh shares today, compared to the daily average of 21.43 lakh shares in last one month. The benchmark September futures contract for the stock is quoting at Rs 497.85, up 4.08% on the day. Laurus Labs Ltd is up 21.9% in last one year as compared to a 28.41% spurt in NIFTY and a 52.01% spurt in the Nifty Pharma index.The PE of the stock is 107.07 based on TTM earnings ending June 24.Powered by Capital Market - Live

Laurus Labs Ltd rose for a fifth straight session today. The stock is quoting at Rs 443.5, up 1.39% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.11% on the day, quoting at 24726.7. The Sensex is at 80745.92, down 0.07%. Laurus Labs Ltd has added around 0.45% in last one month. Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has added around 9.31% in last one month and is currently quoting at 22374.25, up 0.85% on the day. The volume in the stock stood at 6.56 lakh shares today, compared to the daily average of 29.12 lakh shares in last one month. The benchmark August futures contract for the stock is quoting at Rs 444.05, up 1.25% on the day. Laurus Labs Ltd is up 13.35% in last one year as compared to a 27.48% gain in NIFTY and a 47.45% gain in the Nifty Pharma index.The PE of the stock is 98.42 based on TTM earnings ending June 24.Powered by Capital Market - Live

Laurus Labs Ltd gained for a third straight session today. The stock is quoting at Rs 435.5, up 1.4% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.14% on the day, quoting at 24574.45. The Sensex is at 80465.57, up 0.04%. Laurus Labs Ltd has slipped around 1.36% in last one month. Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has slipped around 7.84% in last one month and is currently quoting at 22106.5, up 0.69% on the day. The volume in the stock stood at 6.04 lakh shares today, compared to the daily average of 30.63 lakh shares in last one month. The benchmark August futures contract for the stock is quoting at Rs 435.6, up 0.93% on the day. Laurus Labs Ltd is up 12.03% in last one year as compared to a 26.71% spurt in NIFTY and a 45.17% spurt in the Nifty Pharma index.The PE of the stock is 96.89 based on TTM earnings ending June 24.Powered by Capital Market - Live